Chalela Roberto, Caguana Oswaldo, Zuccarino Flavio, Khilzi Karys, Rodríguez-Chiaradía Diego A
Respiratory Medicine Department, Hospital del Mar, Barcelona, Spain.
Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), Barcelona, Spain.
Vasc Health Risk Manag. 2020 Nov 20;16:463-466. doi: 10.2147/VHRM.S266659. eCollection 2020.
infection is predominantly a respiratory disease with a diverse clinical spectrum. Pulmonary thromboembolic complications during COVID-19 pneumonia may be associated with a high mortality rate and post-mortem findings confirm the presence of platelet-fibrin thrombi in arterial vessels of patients together with lung tissue alterations. We present a patient transferred to the emergency department due to a syncope with no other associated symptoms, who was diagnosed with an acute pulmonary embolism (PE) concomitant with infection without lung infiltrates. Presenting with a PE as the only manifestation of this infection, reinforces our conception of COVID-19 as a heterogeneous disease of which we still know very little. We believe that while the virus is still circulating in our environment, we need to consider ruling out COVID-19 in all thrombotic events, even if the patients have no other risk factors.
感染主要是一种具有多种临床谱的呼吸道疾病。COVID-19肺炎期间的肺血栓栓塞并发症可能与高死亡率相关，尸检结果证实患者动脉血管中存在血小板纤维蛋白血栓以及肺组织改变。我们报告一名因晕厥被送往急诊科且无其他相关症状的患者，该患者被诊断为急性肺栓塞（PE）合并感染但无肺部浸润。以PE作为这种感染的唯一表现，强化了我们将COVID-19视为一种我们仍知之甚少的异质性疾病的观念。我们认为，在病毒仍在我们的环境中传播时，即使患者没有其他危险因素，我们也需要考虑在所有血栓形成事件中排除COVID-19。
